Literature DB >> 33859216

Impact of monthly headache days on anxiety, depression and disability in migraine patients: results from the Spanish Atlas.

P Irimia1,2,3, M Garrido-Cumbrera4, S Santos-Lasaosa5,6,7, M Aguirre-Vazquez8, J Correa-Fernández4, I Colomina9, P Pozo-Rosich5,10,11.   

Abstract

Identifying highly disabled patients or at high risk of psychiatric comorbidity is crucial for migraine management. The burden of migraine increases with headache frequency, but the number of headache days (HDs) per month after which disability becomes severe or the risk of anxiety and depression is higher has not been established. Here, we estimate the number of HDs per month after which migraine is associated with higher risk of anxiety and depression, severe disability and lower quality of life. We analysed 468 migraine patients (mean age 36.8 ± 10.7; 90.2% female), of whom 38.5% had ≥ 15 HDs per month. Our results show a positive linear correlation between the number of HDs per month and the risk of anxiety (r = 0.273; p < 0.001), depression (r = 0.337; p < 0.001) and severe disability (r = 0.519; p < 0.001). The risk of anxiety is higher in patients having ≥ 3HDs per month, and those with ≥ 19HDs per month are at risk of depression. Moreover, patients suffering ≥ 10HDs per month have very severe disability. Our results suggest that migraine patients with ≥ 10HDs per month are very disabled and also that those with ≥ 3HDs per month should be screened for anxiety.

Entities:  

Year:  2021        PMID: 33859216     DOI: 10.1038/s41598-021-87352-2

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  5 in total

1.  Health-related quality of life and associated factors in Chinese menstrual migraine patients: a cross-sectional study.

Authors:  Wenxiu Luo; Xing Cao; Jiayu Zhao; Jiaming Yang; Yu Cen; Jinlong He; Jing Luo; Yunling Zhong; Ying Luo; Xinyue Wang; Liqiu Yang; Xingyu Feng; Xiaoqing Pang; Jiazhu Zhang; Jiaming Luo
Journal:  BMC Womens Health       Date:  2022-05-15       Impact factor: 2.742

2.  Migraine and Happiness.

Authors:  Heiko Pohl; Anne-Catherine Streit; Maria S Neumeier; Gabriele S Merki-Feld; Willibald Ruch; Andreas R Gantenbein
Journal:  Womens Health Rep (New Rochelle)       Date:  2022-02-02

Review 3.  Applying a biopsychosocial model to migraine: rationale and clinical implications.

Authors:  Chiara Rosignoli; Raffaele Ornello; Agnese Onofri; Valeria Caponnetto; Licia Grazzi; Alberto Raggi; Matilde Leonardi; Simona Sacco
Journal:  J Headache Pain       Date:  2022-08-11       Impact factor: 8.588

4.  Isotretinoin and adverse neuropsychiatric outcomes: retrospective cohort study using routine data.

Authors:  Tapio Paljarvi; Tess McPherson; Sierra Luciano; Kimmo Herttua; Seena Fazel
Journal:  Br J Dermatol       Date:  2022-04-12       Impact factor: 11.113

5.  Assessment and characteristics of Erenumab therapy on migraine management.

Authors:  Haitham Saeed; Alaa S Tulbah; Amr Gamal; Marwa Kamal
Journal:  Saudi Pharm J       Date:  2022-06-22       Impact factor: 4.562

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.